NGM - Ngm Biopharmaceuticals Inc
Close
1.54
-0.020 -1.299%
Share volume: 0
Last Updated: Thu 04 Apr 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.56
-0.02
-1.28%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-05 | 2022-08-04 | 2022-11-03 | 2023-02-28 | 2023-05-04 | 2023-08-03 | 2023-11-02 | |
| Cash flow financing | 668.000 K | 19.624 M | 33.218 M | 723.000 K | 279.000 K | 1.385 M | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -35.738 M | -50.151 M | -28.146 M | -30.404 M | -41.827 M | -40.248 M | -27.164 M | |
| Net income | -32.450 M | -46.519 M | -47.261 M | -36.437 M | -47.647 M | -38.261 M | -28.797 M | |
| Depreciation | 1.427 M | 1.396 M | 598.000 K | 614.000 K | 609.000 K | 559.000 K | 535.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 103.000 K | 6.674 M | 4.380 M | 7.580 M | 1.257 M | 736.000 K | 0.000 | |
| Investing Cashflow | -6.853 M | -15.966 M | 35.453 M | 1.688 M | 35.641 M | 24.585 M | 26.869 M | |
| Net Borrowings | -328.293 M | -304.185 M | -304.632 M | -275.894 M | -235.700 M | -199.416 M | -172.658 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -285.000 K | -822.000 K | -310.000 K | -441.000 K | -670.000 K | -104.000 K | -290.000 K | |
| Cash Change | 329.832 M | 297.808 M | 300.150 M | 271.492 M | 231.004 M | 193.544 M | 166.045 M |